Abstract

ABSTRACTDespite longstanding recommendations for routine vaccination against influenza; pneumococcal; tetanus, diphtheria, acellular pertussis (Tdap); and herpes zoster (HZ) among the United States general adult population, vaccine uptake remains low. Understanding factors that influence adult vaccination and coverage variability beyond the national level are important steps toward developing targeted strategies for increasing vaccination coverage. A retrospective analysis was conducted using data from the Behavioral Risk Factor Surveillance System (2011–2014). Multivariable logistic regression modeling was employed to identify individual factors associated with vaccination (socio-demographics, health status, healthcare utilization, state of residence) and generate adjusted vaccination coverage and compliance estimates nationally and by state. Results indicated that multiple characteristics were consistently associated with a higher likelihood of vaccination across all four vaccines, including female sex, increased educational attainment, and annual household income. Model-adjusted vaccination coverage estimates varied widely by state, with inter-state variability for the most recent year of data as follows: influenza (aged ≥18 years) 30.2–49.5%; pneumococcal (aged ≥65 years) 64.0–74.7%; Tdap (aged ≥18 years) 18.7–46.6%; and HZ (aged ≥60 years) 21.3–42.9%. Model-adjusted compliance with age-appropriate recommendations across vaccines was low and also varied by state: influenza+Tdap (aged 18–59 years) 7.9–24.7%; influenza+Tdap+HZ (aged 60–64 years) 4.1–14.4%; and influenza+Tdap+HZ+pneumococcal (aged ≥65 years) 3.0–18.3%. In summary, after adjusting for individual characteristics associated with vaccination, substantial heterogeneity across states remained, suggesting that other local factors (e.g. state policies) may be impacting adult vaccines uptake. Further research is needed to understand such factors, focusing on differences between states with high versus low vaccination coverage.

Highlights

  • The United States (US) Department of Health and Human Services estimate that approximately 42,000 adults die each year in the US from vaccine-preventable diseases.[1]

  • Our study examined individual factors associated with vaccination and generated adjusted vaccination coverage/compliance estimates nationally and by state

  • Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine, with a tetanus-diphtheria (Td) booster every 10 years; a herpes zoster (HZ) vaccination for individuals aged 60 years; and a dose of pneumococcal 13-valent conjugate (PCV13) vaccine and pneumococcal polysaccharide (PPSV23) vaccine administered in series for individuals aged 65 years

Read more

Summary

Introduction

HUMAN VACCINES & IMMUNOTHERAPEUTICS tetanus, diphtheria, and acellular pertussis (Tdap) vaccine, with a tetanus-diphtheria (Td) booster every 10 years; a herpes zoster (HZ) vaccination for individuals aged 60 years; and a dose of pneumococcal 13-valent conjugate (PCV13) vaccine and pneumococcal polysaccharide (PPSV23) vaccine administered in series for individuals aged 65 years. Despite these longstanding guidelines, national adult vaccination coverage for routine vaccines remains low

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call